Podcast: Investigating Resveratrol’s Relationship with Gut Microbiota

May 8th, 2018 | Posted By: Clare Panchoo | Posted in News | Tagged , , , , , , , , , , , , ,

Podcast recorded by Jade Sterling, Associate Editor Vitafoods Insights 

Evolva and Northumbria University’s Brain, Performance and Nutrition Research Centre have teamed up to study resveratrol on human health. As Clare Panchoo, Evolva, and Dr Emma Wightman, Northumbria University, explain, while research has shown resveratrol’s benefits on blood flow, cardiovascular health and cognitive function, no research has directly examined the interrelationship with gut microbiota. Research does show consuming polyphenols, including resveratrol, can positively benefit gut microbiota, making this an area of scientific interest.

We discuss the trials the collaboration will conduct to assess resveratrol’s impact on the gut, while also covering the issue of trusting an ingredient supplier in clinical research and the need for transparency in ingredient supply.

 

Dr Emma Wightman, PhD will be speaking this year at the Vitafoods Education Programme:

Evaluating the Cutting-Edge Work on the Cognitive and Mood Effects of Resveratrol

Tuesday, 15th May 15:50-16:20, Research and Development Forum 1, VitaFoods Europe, Palexpo, Geneva

Dr. Wightman’s presentation will explore:

  • The potential role of resveratrol on cognition and mood in hypoxia
  • Effects of resveratrol in older adults
  • How the gut microbiota may impact the effects of resveratrol

About Dr. Emma Wightman

Dr. Emma Wightman is a Senior Lecturer in Psychology at Northumbria University (UK).  Dr. Wightman leads a polyphenol research group within the Brain Performance and Nutrition Research Centre (BPNRC) within the University. Her research is focused on the investigation of the effects of polyphenols on the cognitive, mood and cerebral blood flow effects. Dr. Wightman is currently leading a study on the effects of resveratrol supplementation on gut microbiota, systemic inflammation and brain function using Veri-te™ resveratrol. Study results are due by the end of this year.